It is sad that there is a grab at corruption and wealth for
It is sad that there is a grab at corruption and wealth for some pharmaceutical companies. Not just here but around the world. Like Your example in India.
I wonder what the driving forces are beside just money for the current big Pharmaceutical company. Is there real hope that science will prevail and even though they have no repeatable verified proof of efficacy. Yet they seek approval just for the mighty dollar? Hoping nobody will say that it doesn’t work? Does it matter that it didn’t work to them? Will they be forced to repay the money like the 500 million the E.U. spent the day before WHO came out and said Remdesivir doesn’t do anything. Will they repay the money the US spent too and any other country that bought Remdesivir? Will they have to be sued after the pandemic. What liability will Gilead have for those bamboozled by Gilead? How much liability will the FDA have in this, not only EUA but BLA full approval? How do they justify full approval without improved results after the EUA?
I wonder if there is a free pass written into these pandemic situations where drugs are immune from liability and maybe the FDA are also immune during this time? If immunity is somehow true then this is a huge corruptible situation. What are the reasons anyone would be involved in this unfounded situation of approvals. Is it only grab the money before they figure out we don’t really work? Is it the government hoping the modest at best results will give hope to the people that need critical help most? That hope alone is so important to healing some people. How does one justify these moves from either position? Government regulator or pharmaceutical.
Why is there this grab at huge money with just hope and a prayer that it might work? Some companies like us pay the price and have to prove without a doubt we work but some companies push and push to sew ideas of miracles that don’t really happen and get preferred handling.
There use to be a time that the government performed these trials and the trials must of been much more fair for all companies. No money influence dominated. Maybe as a country or a world society we need to return to those days before the next pandemic? Maybe it’s time to not let the fox watch the hen house and hope the Fox doesn’t take what he wants when he wants. Maybe it time that the science truly dictates and the government levels the playing field amongst all companies striving to save lives by government controlled trials again?
Do we need HHS and FDA reform? Should the government do the trials for the drug companies like they use to? Will the world be smart enough to change the process for what we know will undoubtedly happen again in the next pandemic? Can we afford to let all this happen again?
Can we change the worlds perception of big Pharma’s dominance politically to make a level playing field? I believe it starts with political donations to our elected officials. Change the power of the businesses in this country and put it back in the hands of the people. Stop business donations to any political race or candidate. This influence is ruining our country and it really shows now in a pandemic more than ever. The average American isn’t doing better competing with big business for a government that was designed for the people by the people. I don’t remember it having business for the business anywhere in the constitution.
Sorry for the rant
5
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
A New Chapter in Guangdong's Economic Story Swing by the bustling streets of Shenzhen, and you'll catch more than a whiff of change in the air. With China gearing up to host the APEC Economic Leaders' Meeting for the third time, Guangdong is under the magnifying glass. But it's not just the international attention landing on the province that’s worth the chatter —...
Continue Reading
A New Player in Town: Beef 'O' Brady's Lands in Tuscaloosa Listen up, sports fans and pub grub lovers of Tuscaloosa! Beef 'O' Brady's just kicked down the doors and expanded its reach, opening a location smack on McFarland Boulevard. The place threw open its doors on October 26 and is set to make waves in the local scene, driven by the dedicated hands of Mitul Patel and...
Continue Reading
Thunes' Network Expands to Bhutan: A Game Changer I'll say one thing clear—Thunes isn't messing around. They've just opened the gates for real-time payouts to Bhutan, and it's going to be a game-changer for those living abroad who want to send money back home. Look, for years, Non-Resident Bhutanese have been diving into hoops just to get their bucks across borders....
Continue Reading
Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...
Continue Reading
Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...
Continue Reading
Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...
Continue Reading
Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...
Continue Reading
New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...
Continue Reading
Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...
Continue Reading
LONGi's Vision: A Cleaner, Greener Future Amidst the buzz at COP31 in Antalya, LONGi is making waves with promises of a cleaner future. They're not just throwing around eco-friendly slogans—this company's laying down real pathways to tackle climate change, one solar panel at a time. Aiming for Industrial Transformation LONGi's got their sights set on shaking up...
Continue Reading
Top 5 Most Recently Viewed Articles
Trade Developments Impacting Global Stocks During the latest trading session in Asia, futures for the S&P 500 and Nasdaq 100 showed positive momentum, increasing by 0.5% and 0.6% respectively. This positive trend comes after Friday's historic closing levels. The surge in optimism can be largely attributed to developments surrounding a trade agreement between the US and...
Continue Reading
Subaru Champions Youth Soccer with Gear for Good Initiative Subaru of America is proud to announce its engaging initiative, Gear for Good, aimed at nurturing the budding talent in youth soccer. This project represents Subaru's unwavering commitment to community involvement, ensuring that every child has access to the necessary tools to pursue their passion for soccer....
Continue Reading
Nykredit's Mortgage Bond Auction Overview Nykredit Realkredit A/S, a prominent financial institution, is organizing an exciting auction designed for interested investors. This event aims to enhance participation in the mortgage bond market, making it a notable opportunity for those seeking investment options. What to Expect at the Auction Scheduled for a future date, the...
Continue Reading
Paperclip Collaborates with Apis Productions for Enhanced Security In an exciting new development, Paperclip, Inc. (OTCMKTS: PCPJ) has announced its partnership with Apis Productions to launch cutting-edge data security solutions. This collaboration focuses on integrating Paperclip’s innovative SAFE encryption technology within Apis Productions’ insurance technology...
Continue Reading
Overview of the Medical Imaging Equipment Services Market The Medical Imaging Equipment Services Market is set for a period of substantial growth, with projections indicating an increase from USD 60 billion in 2024 to USD 85 billion by 2031. This growth trajectory correlates with a compound annual growth rate (CAGR) of 5.0%. Several factors are contributing to this steady...
Continue Reading